US 12668922 — Patent Expiration

ROLL COVER AND ROLL

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US12668922

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn how PTE is calculated

US 12668922

Roll Cover And Roll

High Confidence

Application No. 18503713

December 13, 2042

16y 115d remaining

Could not fetch continuity data for application PCTEP2022058221: Resource not found (404)

Application 18503502 has not been granted a patent number

Earliest effective filing

Mar 29, 2022

+ 20 years

Mar 29, 2042

PTA +259d

Dec 13, 2042

TD applied

Dec 13, 2042

Final

Dec 13, 2042

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Note: terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation Details

Base Term Calculation

Filing Date

November 7, 2023

Earliest Effective Filing

March 29, 2022

Issue Date

June 30, 2026

PTA

+259 days

Base Expiry (before PTA)

March 29, 2042

March 29, 2022 + 20 years = March 29, 2042 + 259 PTA days = December 13, 2042

Continuation of application PCTEP2022058221, filed Mar 29, 2022

Terminal Disclaimer Analysis

TD Approved

1 approved, 1 filed

TD caps expiration to December 13, 2042

US 12668922(App. 18503713)(from app 18503713)

Capping Patent

Roll Cover And Roll

Filing Date

Nov 7, 2023

Earliest Effective Filing

Mar 29, 2022

Issue Date

Jun 30, 2026

PTA

+259 days

Calculated Expiration

Dec 13, 2042

Continuation of PCTEP2022058221, filed Mar 29, 2022

Mar 29, 2022 + 20y + 259d PTA = Dec 13, 2042

US APP:18503502(from app 18503502)

Could not resolve calculation details

Who owns this patent?

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.